October 30, 2023
Chuikyo Joint Meeting of Drug Pricing & CEA Subcommittees on Oct. 27 Japan’s reimbursement policy panel on October 27 held discussions on the potential impact of Alzheimer’s therapy Leqembi (lecanemab) on long-term care costs by inviting a data expert to...read more